The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases, but its underlying mechanism is poorly understood. Here we show that hepatocyte nuclear factor 4α (HNF4α), a liver-enriched nuclear hormone receptor, is markedly inhibited, whereas miR-34a is highly induced in patients with non-alcoholic steatohepatitis, diabetic mice and mice fed a high-fat diet. miR-34a is essential for HNF4α expression and regulates triglyceride accumulation in human and murine hepatocytes. miR-34a inhibits very low-density lipoprotein secretion and promotes liver steatosis and hypolipidemia in an HNF4α-dependent manner. As a result, increased miR-34a or reduced HNF4α expression in the liver attenuates the development of atherosclerosis in Apoe−/− or Ldlr−/− mice. These data indicate that the miR-34a-HNF4α pathway is activated under common conditions of metabolic stress and may have a role in the pathogenesis of NAFLD and in regulating plasma lipoprotein metabolism. Targeting this pathway may represent a novel approach for the treatment of NAFLD. The nuclear hormone receptor HNF4α is important for liver function. Here, Xu et al.show that miR-34a regulates expression of HNF4α and is increased under conditions of metabolic stress, suggesting miR-34a promotes the development of non-alcoholic fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Hayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107
MicroRNAs 103 and 107 regulate insulin sensitivity
Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Self-citationTarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 923
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., Kellum, J. M., Min, H., Luketic, V. A., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22569 · Cited by 658
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N., & Beretta, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023937 · Cited by 564
Nonalcoholic Fatty Liver Disease: A Review and Update
Lewis, J. R., & Mohanty, S. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1081-0 · Cited by 345
Apolipoprotein synthesis in nonalcoholic steatohepatitis
Charlton, M., Sreekumar, R., Rasmussen, D., Lindor, K., & Nair, S. K. (2002) · Hepatology · doi:10.1053/jhep.2002.32527 · Cited by 333
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids
Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D., Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Miller, A. B., et al. (2002) · Structure · doi:10.1016/s0969-2126(02)00829-8 · Cited by 311
Fernández-Hernando, C., Suárez, Y., Rayner, K. J., & Moore, K. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283428d9d · Cited by 308
Soh, J., Iqbal, J., Queiroz, J., Fernandez-Hernando, C., & Hussain, M. M. (2013) · Nature Medicine · doi:10.1038/nm.3200 · Cited by 301
Crystal Structure of the HNF4α Ligand Binding Domain in Complex with Endogenous Fatty Acid Ligand
Dhe-Paganon, S., Duda, K., Iwamoto, M., Chi, Y.-I., & Shoelson, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200420200 · Cited by 286
Fat in the liver and insulin resistance
Yki‐Järvinen, H. (2005) · Annals of Medicine · doi:10.1080/07853890510037383 · Cited by 268
Lee, J., Padhye, A., Sharma, A., Song, G., Miao, J., Mo, Y.-Y., Wang, L., & Kemper, J. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094524 · Cited by 263
Choi, S., Fu, T., Seok, S., Kim, D., Yu, E., Lee, K., Kang, Y., Li, X., Kemper, B., & Kemper, J. K. (2013) · Aging Cell · doi:10.1111/acel.12135 · Cited by 249
Drewes, T., Senkel, S., Holewa, B., & Ryffel, G. U. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.925 · Cited by 246
Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M., Sousa, A., & Wands, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.042 · Cited by 193
FXR Deficiency Causes Reduced Atherosclerosis in Ldlr−/−Mice
Zhang, Y., Wang, X., Vales, C., Lee, F. Y., Lee, H., Lusis, A. J., & Edwards, P. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235697.35431.05 · Cited by 169
Self-citationMiura, A., Yamagata, K., Kakei, M., Hatakeyama, H., Takahashi, N., Fukui, K., Nammo, T., Yoneda, K., Inoue, Y., Sladek, F. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507496200 · Cited by 163
Yin, L., Ma, H., Ge, X., Edwards, P. A., & Zhang, Y. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.217828 · Cited by 157
Self-citationXu, J., Li, Y., Chen, W.-D., Xu, Y., Yin, L., Ge, X., Jadhav, K., Adorini, L., & Zhang, Y. (2013) · Hepatology · doi:10.1002/hep.26714 · Cited by 154
Self-citationShih, D. Q., Dansky, H. M., Fleisher, M., Assmann, G., Fajans, S. S., & Stoffel, M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.832 · Cited by 151
Bile acid receptors in non-alcoholic fatty liver disease
Li, Y., Jadhav, K. S., & Zhang, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.015 · Cited by 140
Self-citationLoss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice
Zhang, Y., Ge, X., Heemstra, L. A., Chen, W., Xu, J., Smith, J. L., Ma, H., Kasim, N., Edwards, P. A., & Novak, C. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1157 · Cited by 128
Self-citationp53 Involvement in the Pathogenesis of Fatty Liver Disease
Yahagi, N., Shimano, H., Matsuzaka, T., Sekiya, M., Najima, Y., Okazaki, S., Okazaki, H., Tamura, Y., Iizuka, Y., Inoue, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400884200 · Cited by 127
Inoue, Y., Hayhurst, G. P., Inoue, J., Mori, M., & Gonzalez, F. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203126200 · Cited by 104
MicroRNAs: emerging roles in lipid and lipoprotein metabolism
Sacco, J., & Adeli, K. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283534c9f · Cited by 104
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism.
Lehto, M. J., Bitzén, P. ‐., Isomaa, B., Wipemo, C., Wessman, Y., Forsblom, C. M., Tuomi, T., Taskinen, M., & Groop, L. (1999) · Diabetes · doi:10.2337/diabetes.48.2.423 · Cited by 100
Treatment of nonalcoholic fatty liver disease
Angulo, P. (2002) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32187-8 · Cited by 100
Zhang, Y., Yin, L., & Hillgartner, F. B. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200283-jlr200 · Cited by 99
Self-citationJiang, S. S., Tanaka, T., Iwanari, H., Hotta, H., Yamashita, H., Kumakura, J., Watanabe, Y., Uchiyama, Y., Aburatani, H., Hamakubo, T., et al. (2003) · Nuclear Receptor · doi:10.1186/1478-1336-1-5 · Cited by 94
Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis
Ge, X., Yin, L., Ma, H., Li, T., Chiang, J. Y. L., & Zhang, Y. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m015859 · Cited by 49
Self-citationControl of ACAT2 Liver Expression by HNF4α
Pramfalk, C., Karlsson, E., Groop, L., Rudel, L. L., Angelin, B., Eriksson, M., & Parini, P. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.188581 · Cited by 31
Cited by
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
MicroRNA-mediated regulation of glucose and lipid metabolism
Agbu, P., & Carthew, R. W. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00354-w · Cited by 363
Harrison, S. A., Ratziu, V., Boursier, J., Francque, S., Bedossa, P., Majd, Z., Cordonnier, G., Sudrik, F. B., Darteil, R., Liebe, R., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30252-1 · Cited by 255
Xu, Y., Li, F., Zalzala, M., Xu, J., Gonzalez, F. J., Adorini, L., Lee, Y., Yin, L., & Zhang, Y. (2016) · Hepatology · doi:10.1002/hep.28712 · Cited by 172
Self-citation
Metadata
- Authors
- Xu, Y., Zalzala, M., Xu, J., Li, Y., Yin, L., & Zhang, Y.
- Venue
- Nature Communications
- Published
- 2015-06-23
- Volume
- 6
- Issue
- 1
- Pages
- 7466-7466
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2260144515
- Cited by
- 277
- References
- 45
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.